TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY Trademark

Trademark Overview

On Monday, August 3, 2009, a trademark application was filed for TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY with the United States Patent and Trademark Office. The USPTO has given the TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY trademark a serial number of 77795574. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 10, 2012. This trademark is owned by Bristol-Myers Squibb Company. The TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
time-point: tanespimycin in myeloma evaluation: performance of hsp 90 inhibitor as initial therapy

General Information

Serial Number77795574
Word MarkTIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY
Filing DateMonday, August 3, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 10, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2010

Trademark Statements

Disclaimer with Predetermined Text"TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 6, 2009
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, September 10, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 10, 2012ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, January 24, 2012EXTENSION 3 GRANTED
Monday, January 23, 2012EXTENSION 3 FILED
Monday, January 23, 2012TEAS EXTENSION RECEIVED
Saturday, June 25, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, June 24, 2011EXTENSION 2 GRANTED
Wednesday, June 15, 2011EXTENSION 2 FILED
Monday, June 20, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 15, 2011TEAS EXTENSION RECEIVED
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, January 24, 2011EXTENSION 1 GRANTED
Monday, January 24, 2011EXTENSION 1 FILED
Monday, January 24, 2011TEAS EXTENSION RECEIVED
Tuesday, August 10, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 15, 2010PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2010NOTICE OF PUBLICATION
Wednesday, May 12, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 12, 2010ASSIGNED TO LIE
Monday, May 3, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 12, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 12, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 12, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 28, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 28, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 6, 2009NON-FINAL ACTION MAILED
Thursday, November 5, 2009NON-FINAL ACTION WRITTEN
Thursday, October 29, 2009ASSIGNED TO EXAMINER
Thursday, August 6, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 6, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

inhibitor initial therapy performance evaluation point tanespimycin myeloma time clinical relating pharmaceutical preparations human studies trials research namely conducting